ATE359798T1 - Verwendungvon dextransulfat zur behandlung von ibmir - Google Patents
Verwendungvon dextransulfat zur behandlung von ibmirInfo
- Publication number
- ATE359798T1 ATE359798T1 AT03811973T AT03811973T ATE359798T1 AT E359798 T1 ATE359798 T1 AT E359798T1 AT 03811973 T AT03811973 T AT 03811973T AT 03811973 T AT03811973 T AT 03811973T AT E359798 T1 ATE359798 T1 AT E359798T1
- Authority
- AT
- Austria
- Prior art keywords
- dextransulphate
- ibmir
- treat
- human patient
- cell transplant
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 abstract 3
- 229960000633 dextran sulfate Drugs 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/721—Dextrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/39—Pancreas; Islets of Langerhans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/64—Animal cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Transplantation (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Botany (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0203526A SE525461C3 (sv) | 2002-11-28 | 2002-11-28 | Ny användning av dextransulfat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE359798T1 true ATE359798T1 (de) | 2007-05-15 |
Family
ID=20289705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03811973T ATE359798T1 (de) | 2002-11-28 | 2003-11-26 | Verwendungvon dextransulfat zur behandlung von ibmir |
Country Status (25)
| Country | Link |
|---|---|
| US (5) | US8629123B2 (de) |
| EP (1) | EP1567171B1 (de) |
| JP (2) | JP4315908B2 (de) |
| KR (1) | KR100828807B1 (de) |
| CN (1) | CN1296051C (de) |
| AT (1) | ATE359798T1 (de) |
| AU (1) | AU2003302378B2 (de) |
| BR (1) | BRPI0316666B8 (de) |
| CA (1) | CA2507595C (de) |
| CY (1) | CY1106739T1 (de) |
| DE (1) | DE60313356T2 (de) |
| DK (1) | DK1567171T3 (de) |
| EA (1) | EA010409B1 (de) |
| ES (1) | ES2285270T3 (de) |
| HR (1) | HRP20050439B1 (de) |
| IL (1) | IL168626A (de) |
| IS (1) | IS2405B (de) |
| NO (1) | NO326946B1 (de) |
| NZ (1) | NZ540744A (de) |
| PL (1) | PL216067B1 (de) |
| PT (1) | PT1567171E (de) |
| SE (1) | SE525461C3 (de) |
| SI (1) | SI1567171T1 (de) |
| WO (1) | WO2004047848A1 (de) |
| ZA (1) | ZA200504111B (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110104173A1 (en) * | 2006-10-20 | 2011-05-05 | The Australian National University | Inhibition of degradation of extracellular matrix |
| US20110008343A1 (en) * | 2007-06-08 | 2011-01-13 | Lambris John D | Method Of Reducing Tissue Loss In Pancreatic Islet Cell Transplantation |
| CN102917711A (zh) * | 2010-03-12 | 2013-02-06 | 澳大利亚国立大学 | 硫酸乙酰肝素替代疗法 |
| ES2732819T3 (es) * | 2010-07-16 | 2019-11-26 | Tx Medic Ab | Terapia celular |
| CN102973592A (zh) * | 2012-11-26 | 2013-03-20 | 合肥博太医药生物技术发展有限公司 | 硫酸葡聚糖在制备治疗糖尿病药物中的应用 |
| SE537742C2 (sv) | 2013-05-13 | 2015-10-13 | Tx Medic Ab | Dextransulfat för cellmobilisering |
| GB201408233D0 (en) | 2014-05-09 | 2014-06-25 | Austrianova Singapore Pte Ltd | Use of polyanionic composition |
| AU2015272115B2 (en) | 2014-06-12 | 2019-01-17 | Tx Medic Ab | The use of dextran sulfate having an average molecular weight below 10000 Da for inducing angiogenisis in a subject |
| WO2015190989A1 (en) * | 2014-06-12 | 2015-12-17 | Tx Medic Ab | The use of dextran sulfate having an average molecular weight below 10000 da for inducing angiogenisis in a subject |
| SE538503C2 (en) | 2014-11-11 | 2016-08-16 | Tx Medic Ab | New dextran sulfate |
| SE539575C2 (en) * | 2015-07-30 | 2017-10-17 | Tx Medic Ab | Dextran sulfate for use in treating, inhibiting or preventing cardiac fibrosis |
| IL272935B2 (en) * | 2017-09-08 | 2025-04-01 | Tx Medic Ab | New use of dextran sulfate |
| WO2021211043A1 (en) * | 2020-04-15 | 2021-10-21 | Tx Medic Ab | Treatment of coronavirus infections |
| SE544447C2 (en) * | 2020-09-29 | 2022-05-31 | Tx Medic Ab | Treatment of fatty liver diseases |
| SE544768C2 (en) * | 2021-03-24 | 2022-11-08 | Tx Medic Ab | Combination for treatment of thromboinflammation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0240098A3 (de) * | 1986-04-04 | 1989-05-10 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Oligo und Polysaccharide zur Behandlung von Krankheiten verursacht durch Retroviren |
| IL88554A0 (en) * | 1988-12-01 | 1989-07-31 | Hadassah Med Org | Compositions containing a compound binding to a heparin receptor |
| TW318142B (de) | 1991-06-03 | 1997-10-21 | Mitsubishi Chemicals Co Ltd | |
| US5464815A (en) | 1993-09-08 | 1995-11-07 | Genentech, Inc. | Inhibition of heparin-binding |
| CN1178070A (zh) * | 1996-09-27 | 1998-04-08 | 刘春江 | 组织脏器移植用保存溶液·手术等时组织脏器保护溶液 |
| CN1057192C (zh) * | 1997-09-10 | 2000-10-11 | 上海长征医院 | 一种配制多器官保存液的方法 |
-
2002
- 2002-11-28 SE SE0203526A patent/SE525461C3/sv not_active IP Right Cessation
-
2003
- 2003-11-26 DE DE60313356T patent/DE60313356T2/de not_active Expired - Lifetime
- 2003-11-26 HR HR20050439A patent/HRP20050439B1/xx not_active IP Right Cessation
- 2003-11-26 AT AT03811973T patent/ATE359798T1/de active
- 2003-11-26 PT PT03811973T patent/PT1567171E/pt unknown
- 2003-11-26 WO PCT/SE2003/001830 patent/WO2004047848A1/en not_active Ceased
- 2003-11-26 ES ES03811973T patent/ES2285270T3/es not_active Expired - Lifetime
- 2003-11-26 CA CA2507595A patent/CA2507595C/en not_active Expired - Lifetime
- 2003-11-26 BR BRPI0316666A patent/BRPI0316666B8/pt active IP Right Grant
- 2003-11-26 DK DK03811973T patent/DK1567171T3/da active
- 2003-11-26 SI SI200330809T patent/SI1567171T1/sl unknown
- 2003-11-26 NZ NZ540744A patent/NZ540744A/en not_active IP Right Cessation
- 2003-11-26 EA EA200500757A patent/EA010409B1/ru not_active IP Right Cessation
- 2003-11-26 CN CNB2003801045438A patent/CN1296051C/zh not_active Expired - Lifetime
- 2003-11-26 KR KR1020057009717A patent/KR100828807B1/ko not_active Expired - Lifetime
- 2003-11-26 US US10/535,876 patent/US8629123B2/en not_active Expired - Fee Related
- 2003-11-26 AU AU2003302378A patent/AU2003302378B2/en not_active Expired
- 2003-11-26 JP JP2004555208A patent/JP4315908B2/ja not_active Expired - Lifetime
- 2003-11-26 PL PL376302A patent/PL216067B1/pl unknown
- 2003-11-26 EP EP03811973A patent/EP1567171B1/de not_active Expired - Lifetime
-
2005
- 2005-05-17 IL IL168626A patent/IL168626A/en active IP Right Grant
- 2005-05-20 ZA ZA200504111A patent/ZA200504111B/en unknown
- 2005-05-25 NO NO20052505A patent/NO326946B1/no not_active IP Right Cessation
- 2005-06-23 IS IS7908A patent/IS2405B/is unknown
-
2007
- 2007-07-17 CY CY20071100954T patent/CY1106739T1/el unknown
-
2009
- 2009-03-17 JP JP2009064780A patent/JP4972113B2/ja not_active Expired - Lifetime
-
2010
- 2010-01-11 US US12/685,005 patent/US8906884B2/en not_active Expired - Lifetime
-
2013
- 2013-12-06 US US14/099,518 patent/US8901104B2/en not_active Expired - Lifetime
- 2013-12-06 US US14/099,493 patent/US9364499B2/en not_active Expired - Fee Related
-
2016
- 2016-01-20 US US15/001,380 patent/US10307440B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE359798T1 (de) | Verwendungvon dextransulfat zur behandlung von ibmir | |
| DE60236413D1 (de) | Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten | |
| CY1107850T1 (el) | Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους | |
| DE69634828D1 (de) | Auffindbare künstliche bioimplantate | |
| ATE336255T1 (de) | Hyaluronsäure-ester zur behandlung von normotrophischen hautnarben | |
| WO2004031129A3 (en) | Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection | |
| DE50014532D1 (de) | Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz | |
| EP2364708A3 (de) | PHARMAZEUTISCHE ZUSAMMENSETZUNG, ENTHALTEND EINEN ClC-2-CHANNEL-AKTIVATOR | |
| DE59600683D1 (de) | Verwendung von Trospiumchlorid zur Herstellung eines Arzneimittels zur Behandlung von Blasenkrankheiten | |
| DK1569679T3 (da) | Chaperonin-10-immunosuppression | |
| MXPA02005069A (es) | Agentes de enlace especificos para t3 y metodos para su uso. | |
| ATE316379T1 (de) | Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen | |
| DE60026883D1 (de) | Methoden und zusammensetzungen zur behandlung von schmerzen | |
| HUP0203486A2 (hu) | Véralvadással összefüggő betegségek megelőzése és kezelése | |
| EA200701017A1 (ru) | Применение рибозы-цистеина для лечения гипоксии | |
| DE50103012D1 (de) | Verwendung von hyaluronidase zur prophylaxe und behandlung von herz-kreislauf-erkrankungen | |
| CY1108781T1 (el) | Εμβολιο ψαριων | |
| NO20022109D0 (no) | Anvendelse av treosulfan for behandling av pasienter för benmargs- eller blodstamcelletansplantasjon | |
| DE69904712D1 (de) | Verwendung von deltorphin zur behandlung von zytokin-vermittelter leberschädigung | |
| ATE371446T1 (de) | Zusammensetzungen zur verhinderung der adhäsion | |
| RU99111148A (ru) | Глазные капли | |
| SE0200598D0 (sv) | Pharmaceutical composition and method for treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and/or ischemic consequences | |
| MD1135F1 (en) | Paradontium treatment method | |
| UA36465A (uk) | Спосіб ушивання глибоких і нешироких ран та голка для його здійснення | |
| MD2876C2 (ro) | Remediu biostimulator al sistemului locomotor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1567171 Country of ref document: EP |